Border Patrol and ICE agents have demonstrated a troubling inability to provide developmentally appropriate and humane care ...
Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) ...